3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Operational Research for Cryptococcal Antigen Screening Fluconazole - Cryptococcal Meningitis, Cryptococcus Neoformans | Phase 4 | Completed | University of Minnesota | 3049 | 2012-07-01 | 2020-06-04 |
| Cryptococcal Optimal ART Timing Trial efavirenz, nucleoside - Cryptococcal Meningitis, HIV Infections | Phase 4 | Completed | University of Minnesota | 177 | 2010-11-01 | 2020-06-09 |
| Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis Early antiretroviral therapy - Cryptococcal Meningitis, HIV Infections | Phase 4 | Completed | Botswana-UPenn Partnership | 28 | 2009-09-01 | 2012-02-07 |
Meningitis, Cryptococcal (3) · Acquired Immunodeficiency Syndrome (2) · Cryptococcosis (2) · HIV Infections (2)
Bacterial Infections and Mycoses (3) · Blood-Borne Infections (3) · Central Nervous System Diseases (3) · Central Nervous System Fungal Infections (3) · Central Nervous System Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Infections (3) · Lentivirus Infections (3) · Meningitis (3) · Meningitis, Fungal (3) · Mycoses (3) · Nervous System Diseases (3)
Fluconazole (1) · Lamivudine (1) · Nucleosides (1) · Stavudine (1) · Zidovudine (1) · efavirenz (1)
University of Minnesota (2) · Botswana-UPenn Partnership (1)
Uganda (2) · Botswana (1) · South Africa (1)
David B Meya, MMed (1) · David R Boulware, MD, MPH (1) · Gregory P Bisson, MD,MSCE (1) · Pablo Tebas, MD (1) · Radha Rajasingham, MD (1)
PMID 23362285, PMID 24963568, PMID 30325463, PMID 30399034, PMID 31319498, PMID 31504335, PMID 32843994, PMID 39972326
U01AI089244 (1), U01GH000517 (1)